4
4
4
Over-the-Counter Monograph Drug User Fee Amendments
10/7/2025, 6:55 PM
Summary of Bill S 2292
The bill introduced in the 119th Congress, designated as S. 2292, aims to amend the Federal Food, Drug, and Cosmetic Act to modify and prolong the user fee initiative concerning over-the-counter monograph drugs.
Read the Full Bill
Current Status of Bill S 2292
Bill S 2292 is currently in the status of Bill Introduced since July 15, 2025. Bill S 2292 was introduced during Congress 119 and was introduced to the Senate on July 15, 2025. Bill S 2292's most recent activity was Placed on Senate Legislative Calendar under General Orders. Calendar No. 152. as of September 8, 2025
Bipartisan Support of Bill S 2292
Total Number of Sponsors
1Democrat Sponsors
0Republican Sponsors
1Unaffiliated Sponsors
0Total Number of Cosponsors
1Democrat Cosponsors
1Republican Cosponsors
0Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill S 2292
Primary Policy Focus
HealthPotential Impact Areas
- Congressional oversight
- Drug safety, medical device, and laboratory regulation
- User charges and fees
Alternate Title(s) of Bill S 2292
A bill to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user fee program for over-the-counter monograph drugs, and for other purposes.
A bill to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user fee program for over-the-counter monograph drugs, and for other purposes.
Comments
Coraline Buckley
42,543
7 months ago
I think this bill is good for us. It will help make things better for everyone. I support it because it will make things easier for me and others.
Jalen Ford
42,428
7 months ago
I'm really excited about this bill! It will help make over-the-counter drugs more accessible and affordable for everyone. Can't wait to see the positive impact it has on healthcare in our country. #S2292 #OTCdrugs #healthcarewin
Sponsors and Cosponsors of S 2292
Latest Bills
To authorize the Secretary of Education, in collaboration with the Secretary of Health and Human Services, to establish an interagency advisory Commission on Advancing Restorative Justice in Elementary and Secondary Education, and for other purposes.
Bill HR 8360April 17, 2026
To amend the Higher Education Act of 1965 to remove all adverse credit history related to a loan from the credit history of a borrower who has rehabilitated the loan.
Bill HR 8361April 17, 2026
To reauthorize the YouthBuild program, and for other purposes.
Bill HR 8333April 17, 2026
To raise the Foreign Service mandatory retirement age by aligning it with the Social Security Full Retirement Age, and for other purposes.
Bill HR 8346April 17, 2026
To amend the FISA Amendments Act of 2008 to extend the authorities of title VII of the Foreign Intelligence Surveillance Act of 1978 through April 30, 2026, and for other purposes.
Bill HR 8322April 17, 2026
To amend title II of the Social Security Act to repeal the retirement earnings test, and for other purposes.
Bill HR 8344April 17, 2026
To amend section 133 of title 23, United States Code, to remove a certain State funding set-aside for transportation alternative programs, and for other purposes.
Bill HR 8349April 17, 2026
To amend title XI of the Social Security Act to require the Center for Medicare and Medicaid Innovation to test a model to reduce chronic diseases by using accountable produce is medicine.
Bill HR 8355April 17, 2026
To amend the Federal Food, Drug, and Cosmetic Act to enhance drug manufacturing amount information reporting, and for other purposes.
Bill HR 8339April 17, 2026
Supporting the designation of the week of April 11 through April 17, 2026, as "Black Maternal Health Week", founded by Black Mamas Matter Alliance, Inc. (BMMA), to bring national attention to the maternal and reproductive health crisis in the United States and the importance of reducing maternal mortality and morbidity among Black women and birthing people.
Bill HRES 1183April 17, 2026
Over-the-Counter Monograph Drug User Fee Amendments
Bill HR 4273October 14, 2025
A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches.
Bill S 2529August 7, 2025